SETTING: Medical units at an academic tertiary referral hospital in Southern India. OBJECTIVE: To investigate the impact of solid culture on Löwenstein-Jensen medium on clinical decision making. DESIGN: In a retrospective review of 150 culture-positive and 150 culture-negative consecutively sampled tuberculosis (TB) suspects, treatment decisions were analysed at presentation, after the availability of culture detection results and after the availability of drug susceptibility testing (DST) culture results. RESULTS: A total of 124 (82.7%) culture-positive patients and 35 (23.3%) culture-negative patients started anti-tuberculosis treatment prior to receiving their culture results; 101 patients (33.7%) returned for their results; two (1.3%) initiated treatment based on positive culture and no culture-negative patients discontinued treatment. DST was performed on 119 (79.3%) positive cultures: 30 (25.2%) showed any resistance, eight (6.7%) showed multidrug resistance and one (0.84%) showed extensively drug-resistant TB. Twenty-eight patients (23.5%) returned for their DST results. Based on DST, treatment was modified in four patients (3.4%). CONCLUSION: Using solid culture, 150 cultures need to be tested for one treatment modification and 30 for DST. The cost of the widespread application of culture will need to be balanced against its impact on treatment decisions in India.
SETTING: Medical units at an academic tertiary referral hospital in Southern India. OBJECTIVE: To investigate the impact of solid culture on Löwenstein-Jensen medium on clinical decision making. DESIGN: In a retrospective review of 150 culture-positive and 150 culture-negative consecutively sampled tuberculosis (TB) suspects, treatment decisions were analysed at presentation, after the availability of culture detection results and after the availability of drug susceptibility testing (DST) culture results. RESULTS: A total of 124 (82.7%) culture-positive patients and 35 (23.3%) culture-negative patients started anti-tuberculosis treatment prior to receiving their culture results; 101 patients (33.7%) returned for their results; two (1.3%) initiated treatment based on positive culture and no culture-negative patients discontinued treatment. DST was performed on 119 (79.3%) positive cultures: 30 (25.2%) showed any resistance, eight (6.7%) showed multidrug resistance and one (0.84%) showed extensively drug-resistant TB. Twenty-eight patients (23.5%) returned for their DST results. Based on DST, treatment was modified in four patients (3.4%). CONCLUSION: Using solid culture, 150 cultures need to be tested for one treatment modification and 30 for DST. The cost of the widespread application of culture will need to be balanced against its impact on treatment decisions in India.
Authors: David W Dowdy; Celine R Gounder; Elizabeth L Corbett; Lucky G Ngwira; Richard E Chaisson; Maria W Merritt Journal: Clin Infect Dis Date: 2012-08-23 Impact factor: 9.079
Authors: Henrik Salje; Jason R Andrews; Sarang Deo; Srinath Satyanarayana; Amanda Y Sun; Madhukar Pai; David W Dowdy Journal: PLoS Med Date: 2014-07-15 Impact factor: 11.069
Authors: Simon Walusimbi; Fred Semitala; Freddie Bwanga; Melles Haile; Ayesha De Costa; Lucian Davis; Moses Joloba; Sven Hoffner; Moses Kamya Journal: Pan Afr Med J Date: 2016-03-31
Authors: Monique van Lettow; Ann Åkesson; Alexandra L C Martiniuk; Andrew Ramsay; Adrienne K Chan; Suzanne T Anderson; Anthony D Harries; Elizabeth Corbett; Robert S Heyderman; Rony Zachariah; Richard A Bedell Journal: PLoS One Date: 2012-11-19 Impact factor: 3.240